AVGR vs. PAVM, NXGL, SSKN, PSTV, GCTK, BTCY, PETV, STSS, NURO, and INBS
Should you be buying Avinger stock or one of its competitors? The main competitors of Avinger include PAVmed (PAVM), NEXGEL (NXGL), STRATA Skin Sciences (SSKN), Plus Therapeutics (PSTV), GlucoTrack (GCTK), Biotricity (BTCY), PetVivo (PETV), Sharps Technology (STSS), NeuroMetrix (NURO), and Intelligent Bio Solutions (INBS). These companies are all part of the "surgical & medical instruments" industry.
Avinger (NASDAQ:AVGR) and PAVmed (NASDAQ:PAVM) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, profitability, institutional ownership, risk, analyst recommendations, earnings, media sentiment and community ranking.
Avinger has a net margin of -251.78% compared to PAVmed's net margin of -2,037.67%.
In the previous week, Avinger and Avinger both had 2 articles in the media. Avinger's average media sentiment score of 0.96 beat PAVmed's score of 0.93 indicating that Avinger is being referred to more favorably in the media.
Avinger presently has a consensus target price of $5.00, indicating a potential upside of 133.10%. PAVmed has a consensus target price of $21.00, indicating a potential upside of 1,348.28%. Given PAVmed's higher possible upside, analysts clearly believe PAVmed is more favorable than Avinger.
Avinger has a beta of 1.22, meaning that its share price is 22% more volatile than the S&P 500. Comparatively, PAVmed has a beta of 0.83, meaning that its share price is 17% less volatile than the S&P 500.
Avinger received 192 more outperform votes than PAVmed when rated by MarketBeat users. However, 65.90% of users gave PAVmed an outperform vote while only 59.46% of users gave Avinger an outperform vote.
Avinger has higher revenue and earnings than PAVmed. PAVmed is trading at a lower price-to-earnings ratio than Avinger, indicating that it is currently the more affordable of the two stocks.
18.3% of Avinger shares are owned by institutional investors. Comparatively, 19.9% of PAVmed shares are owned by institutional investors. 11.4% of Avinger shares are owned by insiders. Comparatively, 12.6% of PAVmed shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Summary
Avinger and PAVmed tied by winning 8 of the 16 factors compared between the two stocks.
Get Avinger News Delivered to You Automatically
Sign up to receive the latest news and ratings for AVGR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AVGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
